UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Covariates of tramadol disposition in the first months of life

British journal of anaesthesia : BJA, 2008-04, Vol.100 (4), p.525-532

2008

Volltextzugriff (PDF)

MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans

Journal of psychopharmacology (Oxford), 2011-03, Vol.25 (3), p.314-328

2011

Volltextzugriff (PDF)

Increased C-Reactive Protein in Young Adult Patients with Migraine

Cephalalgia, 2007-07, Vol.27 (7), p.843-846

2007

Volltextzugriff (PDF)

Tramadol and O-Desmethyl Tramadol Clearance Maturation and Disposition in Humans: A Pooled Pharmacokinetic Study

Clinical pharmacokinetics, 2015-02, Vol.54 (2), p.167-178

2015

Volltextzugriff (PDF)

Pharmacokinetics of Drugs in Neonates: Pattern Recognition Beyond Compound Specific Observations

Current pharmaceutical design, 2012-02, Vol.18 (21), p.3119-3146

2012

Volltextzugriff (PDF)

Altered arterial function in migraine of recent onset

Neurology, 2007-05, Vol.68 (19), p.1563-1570

2007

Volltextzugriff (PDF)

Cranial and Peripheral Interictal Vascular Changes in Migraine Patients

Cephalalgia, 2003-03, Vol.23 (2), p.96-104

2003

Volltextzugriff (PDF)

Characterizing the PK/PD relationship for inhibition of capsaicin‐induced dermal vasodilatation by MK‐3207, an oral calcitonin gene related peptide receptor antagonist

British journal of clinical pharmacology, 2015-05, Vol.79 (5), p.831-837

2015

Volltextzugriff (PDF)

Pharmacokinetics, Pharmacodynamics, and Safety of a Prostaglandin D2 Receptor Antagonist

Clinical pharmacology and therapeutics, 2008-06, Vol.83 (6), p.840-847

2008

Volltextzugriff (PDF)

MRK-409 (MK-0343), a GABA A receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans

Journal of psychopharmacology (Oxford), 2011-03, Vol.25 (3), p.314-328

2011

Volltextzugriff (PDF)

Lack of hemodynamic interaction between CGRP-receptor antagonist telcagepant (MK-0974) and sumatriptan: Results from a randomized study in patients with migraine

Cephalalgia, 2013-12, Vol.33 (16), p.1292-1301

2013

Volltextzugriff (PDF)

Reproducibility of the capsaicin‐induced dermal blood flow response as assessed by laser Doppler perfusion imaging

British journal of clinical pharmacology, 2007-11, Vol.64 (5), p.580-590

2007

Volltextzugriff (PDF)

Does the Unfavorable Pharmacokinetic and Pharmacodynamic Profile of the iNOS Inhibitor GW273629 Lead to Inefficacy in Acute Migraine?

Journal of clinical pharmacology, 2009-03, Vol.49 (3), p.281-290

2009

Volltextzugriff (PDF)

Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonist

Journal of psychopharmacology (Oxford), 2011-03, Vol.25 (3), p.329-344

2011

Volltextzugriff (PDF)

Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarin

European journal of clinical pharmacology, 2005-07, Vol.61 (5-6), p.341-346

2005

Volltextzugriff (PDF)

Calcitonin gene-related peptide: Exploring its vasodilating mechanism of action in humans

Clinical pharmacology and therapeutics, 2003-04, Vol.73 (4), p.312-321

2003

Volltextzugriff (PDF)

Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonist

Journal of psychopharmacology (Oxford), 2011-03, Vol.25 (3), p.329-344

2011

Volltextzugriff (PDF)

MRK-409 (MK-0343), a GABA^sub A^ receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans

Journal of psychopharmacology (Oxford), 2011-03, Vol.25 (3), p.314

2011

Volltextzugriff (PDF)

Preclinical and clinical pharmacology of TPA023B, a GABA A receptor α2/α3 subtype-selective partial agonist

Journal of psychopharmacology (Oxford), 2011-03, Vol.25 (3), p.329-344

2011

Volltextzugriff (PDF)

Preclinical and clinical pharmacology of TPA023B, a GABA^sub A^ receptor [alpha]2/[alpha]3 subtype-selective partial agonist

Journal of psychopharmacology (Oxford), 2011-03, Vol.25 (3), p.329

2011

Volltextzugriff (PDF)

Effects of enteric‐coated, low‐dose aspirin on parameters of platelet function

Alimentary pharmacology & therapeutics, 2002-09, Vol.16 (9), p.1683-1688

2002

Volltextzugriff (PDF)

Non-invasive assessment of selective 5-HT1B/1D-receptor agonist-induced peripheral vascular effects in humans: comparison of different techniques

European journal of clinical pharmacology, 2002-08, Vol.58 (5), p.303-308

2002

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of Omarigliptin, a Once-Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, After Single and Multiple Doses in Healthy Subjects

Journal of clinical pharmacology, 2016-12, Vol.56 (12), p.1528-1537

2016

Volltextzugriff (PDF)

Tramadol disposition in the very young: an attempt to assess in vivo cytochrome P-450 2D6 activity

British journal of anaesthesia : BJA, 2005-08, Vol.95 (2), p.231-239

2005

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Covariates of tramadol disposition in the first months of life

MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans

Increased C-Reactive Protein in Young Adult Patients with Migraine

Tramadol and O-Desmethyl Tramadol Clearance Maturation and Disposition in Humans: A Pooled Pharmacokinetic Study

Pharmacokinetics of Drugs in Neonates: Pattern Recognition Beyond Compound Specific Observations

Altered arterial function in migraine of recent onset

Cranial and Peripheral Interictal Vascular Changes in Migraine Patients

Characterizing the PK/PD relationship for inhibition of capsaicin‐induced dermal vasodilatation by MK‐3207, an oral calcitonin gene related peptide receptor antagonist

Pharmacokinetics, Pharmacodynamics, and Safety of a Prostaglandin D2 Receptor Antagonist

MRK-409 (MK-0343), a GABA A receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans

Lack of hemodynamic interaction between CGRP-receptor antagonist telcagepant (MK-0974) and sumatriptan: Results from a randomized study in patients with migraine

Reproducibility of the capsaicin‐induced dermal blood flow response as assessed by laser Doppler perfusion imaging

Does the Unfavorable Pharmacokinetic and Pharmacodynamic Profile of the iNOS Inhibitor GW273629 Lead to Inefficacy in Acute Migraine?

Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonist

Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarin

Calcitonin gene-related peptide: Exploring its vasodilating mechanism of action in humans

Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonist

MRK-409 (MK-0343), a GABA^sub A^ receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans

Preclinical and clinical pharmacology of TPA023B, a GABA A receptor α2/α3 subtype-selective partial agonist

Preclinical and clinical pharmacology of TPA023B, a GABA^sub A^ receptor [alpha]2/[alpha]3 subtype-selective partial agonist

Effects of enteric‐coated, low‐dose aspirin on parameters of platelet function

Non-invasive assessment of selective 5-HT1B/1D-receptor agonist-induced peripheral vascular effects in humans: comparison of different techniques

Pharmacokinetics and Pharmacodynamics of Omarigliptin, a Once-Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, After Single and Multiple Doses in Healthy Subjects

Tramadol disposition in the very young: an attempt to assess in vivo cytochrome P-450 2D6 activity

Early diagnosis is associated with improved clinical outcomes in benign esophageal perforation: an individual patient data meta-analysis

Suchergebnisse filtern